To determine whether the beneficial effects of RSP extract treatment in the C. elegans models of PD and MJD pathogenesis were mediated by GST-4, we assessed the effect of RSP extract supplementation in a gst-4 deletion background [gst-4(ko)]. This evidence concerns the gene GSTM2 and Spinocerebellar ataxia type 3.